title: Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study.
abstract: The purpose of this study is to determine factors associated with a non-ACR 50 response at 6 months of follow-up, in a cohort of patients with early rheumatoid arthritis (RA). Early RA patients (symptom duration <1 year), treated with the same combination treatment (methotrexate and sulfasalazine), were included. Demographic characteristics of the patients including current smoker status (defined as a patient that smokes at least one cigarette per day), years of formal education, a 28-joint count for swelling and tenderness were registered. A basal HAQ questionnaire, visual scales for global assessment, and pain were answered by all patients, and a CDAI basal score was calculated. The ACR 50 response was determined at 6 months follow-up. Multivariable logistic regression analysis was used to calculate adjusted ORs. Two hundred twenty-five patients were evaluated, but only 144 had a complete follow-up, 43% of the latter did not reach an ACR 50 response. The only factor associated with this outcome was current smoking (OR 3.58, P < 0.008, 95% CI 1.23-11.22). Low level of formal education (≤6 years) had a tendency towards a statistical difference (P < 0.08). After controlling with low level of formal education, sex, age in years, and CDAI baseline value with multivariable logistic regression analysis, current smoking status had an adjusted OR of 3.91 (P < 0.009, 95% CI 1.41-10.81). Smoking is associated with a non-ACR 50 response in early rheumatoid arthritis in patients treated with a combination therapy with methotrexate and sulfasalazine.
authors: Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Universidad Nacional Autónoma de México, Faculty of Medicine, Mexico City, Mexico. jrojas@iner.gob.mx
authors: Jorge
authors: J
authors: Rojas-Serrano
authors: Leticia Lino
authors: LL
authors: Pérez
authors: Conrado García
authors: CG
authors: García
authors: Francisco
authors: F
authors: Moctezuma
authors: Everardo
authors: E
authors: Álvarez-Hernández
authors: Janitzia
authors: J
authors: Vázquez-Mellado
authors: José Luis
authors: JL
authors: Montiel
authors: Rubén
authors: R
authors: Burgos-Vargas
references: Arthritis Rheum. 2000 Jan;43(1):14-21
references: 10643695
references: Arthritis Rheum. 1995 Jun;38(6):727-35
references: 7779114
references: Arthritis Rheum. 1998 Jul;41(7):1190-5
references: 9663474
references: Arthritis Rheum. 2006 May;54(5):1366-77
references: 16645965
references: Rheumatology (Oxford). 2009 Dec;48(12):1619-20; author reply 1620
references: 19828599
references: Ann Rheum Dis. 2004 Jun;63(6):675-80
references: 15140774
references: Arthritis Rheum. 1999 May;42(5):910-7
references: 10323446
references: Arthritis Rheum. 2006 Jan;54(1):38-46
references: 16385494
references: J Rheumatol. 1995 Dec;22(12):2208-13
references: 8835550
references: Lancet. 1999 May 8;353(9164):1568-73
references: 10334255
references: Arthritis Rheum. 2000 Jan;43(1):22-9
references: 10643696
references: Arthritis Rheum. 2004 Oct;50(10):3085-92
references: 15476204
references: Lancet. 2002 Apr 6;359(9313):1173-7
references: 11955534
references: Arthritis Rheum. 1996 May;39(5):732-5
references: 8639169
references: Rheumatology (Oxford). 2003 Feb;42(2):244-57
references: 12595618
references: Arthritis Rheum. 2007 Jun;56(6):1765-75
references: 17530705
references: Lancet. 1989 May 13;1(8646):1036-8
references: 2565997
references: J Rheumatol. 2005 Jan;32(1):11-16
references: 15700388
references: Rheumatology (Oxford). 2009 Jun;48(6):613-7
references: 19193698
references: Arthritis Rheum. 1997 Nov;40(11):1955-61
references: 9365083
references: Contraception. 1987 May;35(5):457-64
references: 3621942
references: Lancet. 2004 Jul 17-23;364(9430):263-9
references: 15262104
references: Arthritis Rheum. 1988 Mar;31(3):315-24
references: 3358796
references: Clin Exp Rheumatol. 1993 Mar-Apr;11(2):117-21
references: 8508553